Esketamine depression spray ‘not cost-effective’
Image copyright Getty Images A nasal esketamine spray for hard-to-treat depression has been rejected for use on the NHS for a second time because of uncertainty over cost. Despite a need for new treatments for adults, it is also not clear how well the drug works long term, the healthcare watchdog NICE said. Esketamine is … Read more